Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

4.40
Delayed Data
As of Feb 17
 +0.12 / +2.80%
Today’s Change
3.32
Today|||52-Week Range
9.83
+13.40%
Year-to-Date
No recent news for TapImmune Inc.

Today’s Trading

Previous close4.28
Today’s open4.19
Day’s range4.15 - 4.42
Volume37,200
Average volume (3 months)29,300
Market cap$36.9M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+61.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio6.2
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RTTRRitter Pharmaceutica...-0.16-4.78%
XBIOXenetic Biosciences ...-0.04-0.92%
OHRPOHR Pharmaceutical I...+0.10+10.53%
AXNAoxing Pharmaceutica...-0.00-0.42%
Data as of 3:59pm ET, 02/17/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$34.1M
Net profit margin--

Profile

Sector
Consumer Services
Industry
Other Consumer Services
Chairman, CEO, Secretary &
CAO
Glynn Wilson
President, Chief Operating Officer &
Director
John N. Bonfiglio
Corporate headquarters
Jacksonville, Florida

Forecasts


Search for Jobs